John Dipersio, MD
Enriched profileVirginia E. and Sam J. Golman Professor of Medicine; Section Director, Cellular Therapy, Division of Oncology; Director, Center for Gene and Cellular Immunotherapy; Deputy Director, Siteman Cancer Center · Washington University School of Medicine
John Dipersio is Virginia E. and Sam J. Golman Professor of Medicine; Section Director, Cellular Therapy, Division of Oncology; Director, Center for Gene and Cellular Immunotherapy; Deputy Director, Siteman Cancer Center at Washington University School of Medicine. OpenAlex indexes 1,368 publications with 98,282 citations (h-index 127); ClinicalTrials.gov lists 27 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Medical Oncology profiles in the findmyKOL directory.
Data verified 7 Sept 2026
Overview
Updated 14 Oct 2026
John F. DiPersio, MD, is Virginia E. and Sam J. Golman Professor of Medicine at Washington University School of Medicine, St. Louis, MO. The public record shows 1,368 publications with 98,282 citations (h-index 127), centered on Acute Myeloid Leukemia Research, Hematopoietic Stem Cell Transplantation, Multiple Myeloma Research and Treatments. It also documents an investigator role on 27 registered clinical trials, industry payments reported by 14 companies, 15 NIH-funded awards (1994–2026).
- Most recent indexed publication: 2026 · Clinical cancer research
- Top research focus: Acute Myeloid Leukemia Research
- 27 registered trials on ClinicalTrials.gov
- Open Payments reporting from 14 companies
Generated from the cited public record · current as of 14 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 32 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 507.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 14 Oct 2026
Listed as an investigator on 27 registered studies on ClinicalTrials.gov. The most recent:
- Motixafortide for MRD Sensitization in AML
Sponsor: Washington University School of Medicine
- Recombinant Human IL-7 (NT-I7) in Relapsed/Refractory Multiple Myeloma Following BCMA CAR-T Therapy (Cilta-cel)
Sponsor: Washington University School of Medicine
- NT-I7 (Efineptakin Alfa), a Long-acting Human IL-7, Post-Axicabtagene Ciloleucel or Post-Lisocabtagene Maraleucel in Subjects With Relapsed/Refractory Large B-cell Lymphoma
Sponsor: Washington University School of Medicine
Industry payments
Updated 14 Oct 2026
14 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Geron CorporationProgram year20254 payments
- Janssen Scientific Affairs, LLCProgram year20253 payments
- PFIZER INC.Program year20251 payment
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
45.6%Other antiemetics37.2%Fosaprepitant100%Part B, office-administered≥15 patientsSerotonin-3 Receptor Antagonist5.3%Palonosetron hcl97%Ondansetron Hcl3%Part D + Part B<11 patients+ 5 more classes in this area
Cancer & immunology
36.2%PD-1 inhibitor32.2%Pembrolizumab100%Part B, office-administered≥11 patientsKinase inhibitor3%Jakafi64%Calquence17%Iclusig10%Imbruvica10%Part D<11 patients+ 4 more classes in this area
Sensory organs
8.9%Corticosteroid8.3%Dexamethasone sodium phosphate100%Part B, office-administered≥36 patientsFluoroquinolone Antibacterial0.6%Ciprofloxacin Hcl100%Part D≥21 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 14 Oct 2026
15 NIH research awards on record, funded 1994–2026 per NIH RePORTER. The latest:
- Washington University Paul Calabresi K12 Career Development Award for Clinical Oncology
Washington University
FY2026$809,998K12CA167540 - Optimizing Hematopoietic Stem Cell Transplantation For The Treatment Of Hematological Malignancies
Washington University
FY2026$771,991R35CA210084
Congress activity
Updated 14 Oct 2026
171 congress contributions (2005–2025) across AACR, ASCO, ASH, ESMO per OpenAlex. The most recent:
- BACH2 regulates T cell lineage states to overcome dysfunction driven by tonic CAR signaling
ASH Annual Meeting
ASH2025Co-author
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 14 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- NT-I7, a Long-Acting Interleukin 7, Increases Lymphocyte Counts and Induces CD8+ T-cell Clonotype Expansion in Patients with Newly Diagnosed High-Grade Gliomas.
Clinical cancer research
Clinical Trial2026 - Base Editing of HBG1 and HBG2 Promoters for Sickle Cell Disease.
The New England journal of medicine
Clinical Trial2026 - Advanced deep learning enables prediction of allogeneic stem cell mobilization success.
Bone marrow transplantation
Letter2026
Most-cited works
by citation count (OpenAlex)- 01The Immune Landscape of CancerArticle6,255 citations2018
- 02An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome AnalyticsArticle3,980 citations2018
- 03
- 04Oncogenic Signaling Pathways in The Cancer Genome AtlasArticle3,392 citations2018
- 05Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of CancerArticle2,732 citations2018
Network
Updated 14 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 14 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Other
johndipersiolab.com/dr-john-dipersio
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →johndipersiolab.com ↗ - Doximity
doximity.com/pub/john-dipersio-md
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗
Mentions by others
where others cite or feature them- Instagram
instagram.com/p/DZsIiRKIFSa
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →instagram.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 14 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →oncology.wustl.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →oncology.wustl.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →oncology.wustl.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →oncology.wustl.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →oncology.wustl.edu ↗
Editorial & leadership roles
journal and society appointments- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →sohoinsider.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →oncology.wustl.edu ↗
- Associate Editor
Williams Textbook of Hematology, 11th Edition
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →oncology.wustl.edu ↗ - Steering Committee member
AACR Cancer Immunology Working Group
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →oncology.wustl.edu ↗ - Member
NCI Board of Scientific Counselors
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →sohoonline.org ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →sohoinsider.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →oncology.wustl.edu ↗
- E. Donnall Thomas Prize/Lecture
American Society for Transplantation and Cellular Therapy (ASTCT)
2024verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →siteman.wustl.edu ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →oncology.wustl.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →oncology.wustl.edu ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →research.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →the-asci.org ↗
Secondary affiliations
appointments beyond the home institution- Faculty
Department of Pathology & Immunology, Washington University School of Medicine (Professor, Medicine listing)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →pathology.wustl.edu ↗
Media & interviews
press, podcasts and appearances- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cgtlive.com ↗
- Video interviews/speaker profile on hematopoietic growth factor receptors
GvHD models, and leukemia genomics - VJHemOnc
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →vjhemonc.com ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →bloodcancerstoday.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →onclive.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Douglas Mann, MD
Washington University School of Medicine
Nancy Bartlett, MD
Washington University School of Medicine
Alan Zajarias, MD
Washington University School of Medicine
Hagop Kantarjian, MD
The University of Texas MD Anderson Cancer Center
Jorge Cortes, MD
University of Alabama at Birmingham (UAB)
Ayalew Tefferi, MD
Mayo Clinic
Charles Sawyers, MD
Memorial Sloan Kettering Cancer Center